Prestige Consumer Healthcare Inc (PBH)
ROA
Obliczenia
|
2023 (31 mar 2023) |
2022 (31 mar 2022) |
2021 (31 mar 2021) |
2020 (31 mar 2020) |
2019 (31 mar 2019) |
||
|---|---|---|---|---|---|---|
| Zysk netto | w tys. USD | -82 306 | 205 381 | 164 682 | 142 281 | -35 800 |
| Aktywa razem | w tys. USD | 3 353 730 | 3 670 680 | 3 429 270 | 3 513 900 | 3 441 040 |
| ROA | -2,45% | 5,60% | 4,80% | 4,05% | -1,04% |
2023 obliczenia
ROA = Zysk netto ÷ Aktywa razem
= $-82 306K ÷ $3 353 730K
= -2,45%
Analiza porównawcza
2023
Nazwa spółki
Symbol
ROA
Prestige Consumer Healthcare Inc
PBH
-2,45%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Corcept Therapeutics Inc
CORT
17,08%
Cytokinetics Inc
CYTK
-63,84%
Harmony Biosciences Holdings Inc
HRMY
15,88%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Pacira BioSciences Inc
PCRX
2,66%
Schrodinger Inc
SDGR
5,07%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%